Literature DB >> 16985161

Thin-section CT findings in hematopoietic stem cell transplantation recipients with respiratory virus pneumonia.

Tomas Franquet1, Sonia Rodriguez, Rodrigo Martino, Ana Giménez, Teresa Salinas, Alberto Hidalgo.   

Abstract

OBJECTIVE: The purpose of this study was to use serial thin-section CT scans to assess the incidence of respiratory viral infection and lung abnormalities in a large patient population at high risk of pulmonary complications.
MATERIALS AND METHODS: The study population consisted of 26 recipients of hematopoietic stem cell transplants who had proven respiratory viral pneumonia. In all cases, thin-section CT scans were obtained before fiberoptic bronchoscopy and bronchoalveolar lavage. The study included only patients in whom bronchoalveolar lavage fluid showed no evidence of organisms other than respiratory viruses. The CT scans were assessed for the presence, extent, and anatomic distribution of ground-glass attenuation, air-space consolidation, nodules, centrilobular branching structures (tree-in-bud), thickening of the bronchovascular bundles, and pleural effusion.
RESULTS: Areas of ground-glass attenuation were identified in 24 (92%) of 26 patients and were the only finding in eight patients. Multiple nodules, seen in 17 (65%) of 26 patients, measured 3-10 mm in diameter or were larger than 10 mm. The nodules had a centrilobular or random distribution. A tree-in-bud appearance was seen in six of the patients with centrilobular nodules. This pattern had a bilateral distribution and involved mainly the lower lung zones. CT revealed thickening of the bronchovascular bundles in 16 (61%) of the patients. Thickening was bilateral in 14 and unilateral in two patients. Bronchial wall thickening involved the lower lobes in six patients and had a patchy random distribution in the remaining nine patients. Air-space consolidation was present in nine (35%) of the cases. It had a lobular or subsegmental distribution in eight of the patients and a segmental distribution in one patient. Areas of consolidation were randomly distributed throughout the lungs in all cases. Less common findings included bilateral pleural effusion and bronchial dilatation.
CONCLUSION: Respiratory viral infection is common among adult recipients of hematopoietic stem cell transplants, occurring over a wide time span after transplantation. The presence of respiratory viral infection must be considered in any patient with new respiratory symptoms, fever, or findings at CT such as extensive or patchy areas of ground-glass opacities or a mixture of patterns, most commonly ground-glass attenuation, thickening of the bronchial walls, and multiple small nodules.

Entities:  

Mesh:

Year:  2006        PMID: 16985161     DOI: 10.2214/AJR.05.0439

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Early pulmonary complications related to cancer treatment in children.

Authors:  Cara E Morin; Morgan P McBee; Lama Elbahlawan; Lindsay M Griffin; Gabriela M Maron; HaiThuy N Nguyen; Akshay Sharma; Elizabeth J Snyder; Jean Jeudy
Journal:  Pediatr Radiol       Date:  2022-07-02

2.  Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patients.

Authors:  Brett M Elicker; Brian S Schwartz; Catherine Liu; Eunice C Chen; Steve A Miller; Charles Y Chiu; W Richard Webb
Journal:  Emerg Radiol       Date:  2010-01-29

3.  Potential role of CT-textural features for differentiation between viral interstitial pneumonias, pneumocystis jirovecii pneumonia and diffuse alveolar hemorrhage in early stages of disease: a proof of principle.

Authors:  Christopher Kloth; Wolfgang Maximilian Thaiss; Robert Beck; Michael Haap; Jan Fritz; Meinrad Beer; Marius Horger
Journal:  BMC Med Imaging       Date:  2019-05-21       Impact factor: 1.930

Review 4.  Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.

Authors:  Lauren Fontana; Lynne Strasfeld
Journal:  Infect Dis Clin North Am       Date:  2019-03-30       Impact factor: 5.982

5.  Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome.

Authors:  Cheuk Kei Kathy Wong; Vincent Lai; Yiu Chung Wong
Journal:  Eur J Radiol       Date:  2011-03-25       Impact factor: 3.528

Review 6.  Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies.

Authors:  Margaret L Green
Journal:  Clin Chest Med       Date:  2017-06       Impact factor: 2.878

7.  Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.

Authors:  Christian Renaud; Hu Xie; Sachiko Seo; Jane Kuypers; Anne Cent; Lawrence Corey; Wendy Leisenring; Michael Boeckh; Janet A Englund
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-13       Impact factor: 5.742

8.  CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus.

Authors:  Min-Chul Kim; Mi Young Kim; Hyun Joo Lee; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 9.  Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients.

Authors:  Cécile Pochon; Sebastian Voigt
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

Review 10.  Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.

Authors:  Marie von Lilienfeld-Toal; Annemarie Berger; Maximilian Christopeit; Marcus Hentrich; Claus Peter Heussel; Jana Kalkreuth; Michael Klein; Matthias Kochanek; Olaf Penack; Elke Hauf; Christina Rieger; Gerda Silling; Maria Vehreschild; Thomas Weber; Hans-Heinrich Wolf; Nicola Lehners; Enrico Schalk; Karin Mayer
Journal:  Eur J Cancer       Date:  2016-09-25       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.